Innovations Drugs

Zanvastro Becomes First FDA-Approved Treatment for Alexander Disease 

Zanvastro is an RNA-targeted medicine designed to address the underlying disease mechanism of Alexander Disease by reducing the production of glial fibrillary acidic protein (GFAP).